Cargando…
Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity
The efficacy of cancer immunotherapy depends on the fine interplay between tumoral immune checkpoints and host immune system. However, the up-to-date clinical performance of checkpoint blockers in cancer therapy revealed that higher-level regulation should be further investigated for better therapeu...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426525/ https://www.ncbi.nlm.nih.gov/pubmed/32850399 http://dx.doi.org/10.3389/fonc.2020.01289 |